218 related articles for article (PubMed ID: 21981310)
1. Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency.
Menendez S; Camus S; Herreria A; Paramonov I; Morera LB; Collado M; Pekarik V; Maceda I; Edel M; Consiglio A; Sanchez A; Li H; Serrano M; Belmonte JC
Aging Cell; 2012 Feb; 11(1):41-50. PubMed ID: 21981310
[TBL] [Abstract][Full Text] [Related]
2. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
[TBL] [Abstract][Full Text] [Related]
3. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
[TBL] [Abstract][Full Text] [Related]
4. Cell fate conversion: direct induction of hepatocyte-like cells from fibroblasts.
Ji S; Zhang L; Hui L
J Cell Biochem; 2013 Feb; 114(2):256-65. PubMed ID: 22948752
[TBL] [Abstract][Full Text] [Related]
5. Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro.
Tokumoto Y; Ogawa S; Nagamune T; Miyake J
J Biosci Bioeng; 2010 Jun; 109(6):622-8. PubMed ID: 20471604
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
7. Generation of pig induced pluripotent stem cells with a drug-inducible system.
Wu Z; Chen J; Ren J; Bao L; Liao J; Cui C; Rao L; Li H; Gu Y; Dai H; Zhu H; Teng X; Cheng L; Xiao L
J Mol Cell Biol; 2009 Oct; 1(1):46-54. PubMed ID: 19502222
[TBL] [Abstract][Full Text] [Related]
8. In vitro models of pancreatic differentiation using embryonic stem or induced pluripotent stem cells.
Higuchi Y; Shiraki N; Kume S
Congenit Anom (Kyoto); 2011 Mar; 51(1):21-5. PubMed ID: 21129040
[TBL] [Abstract][Full Text] [Related]
9. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
[TBL] [Abstract][Full Text] [Related]
10. Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging.
Matheu A; Pantoja C; Efeyan A; Criado LM; Martín-Caballero J; Flores JM; Klatt P; Serrano M
Genes Dev; 2004 Nov; 18(22):2736-46. PubMed ID: 15520276
[TBL] [Abstract][Full Text] [Related]
11. Hepatic differentiation of mouse embryonic stem cells and induced pluripotent stem cells during organoid formation in hollow fibers.
Amimoto N; Mizumoto H; Nakazawa K; Ijima H; Funatsu K; Kajiwara T
Tissue Eng Part A; 2011 Aug; 17(15-16):2071-8. PubMed ID: 21457096
[TBL] [Abstract][Full Text] [Related]
12. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.
Takenaka C; Nishishita N; Takada N; Jakt LM; Kawamata S
Exp Hematol; 2010 Feb; 38(2):154-62. PubMed ID: 19922768
[TBL] [Abstract][Full Text] [Related]
13. Modulating Glypican4 suppresses tumorigenicity of embryonic stem cells while preserving self-renewal and pluripotency.
Fico A; De Chevigny A; Egea J; Bösl MR; Cremer H; Maina F; Dono R
Stem Cells; 2012 Sep; 30(9):1863-74. PubMed ID: 22761013
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of endoderm formation efficiency between mouse ES cells and iPS cells.
Iwamuro M; Komaki T; Kubota Y; Seita M; Kawamoto H; Yuasa T; Shahid JM; Hassan RA; Hassan WA; Nakaji S; Nishikawa Y; Kondo E; Yamamoto K; Kobayashi N
Cell Transplant; 2010; 19(6):831-9. PubMed ID: 20955658
[TBL] [Abstract][Full Text] [Related]
15. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
16. MiR-138 promotes induced pluripotent stem cell generation through the regulation of the p53 signaling.
Ye D; Wang G; Liu Y; Huang W; Wu M; Zhu S; Jia W; Deng AM; Liu H; Kang J
Stem Cells; 2012 Aug; 30(8):1645-54. PubMed ID: 22696098
[TBL] [Abstract][Full Text] [Related]
17. Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.
Darini CY; Pisani DF; Hofman P; Pedeutour F; Sudaka I; Chomienne C; Dani C; Ladoux A
Oncogene; 2012 May; 31(19):2438-49. PubMed ID: 21927026
[TBL] [Abstract][Full Text] [Related]
18. [Methionine metabolism regulates maintenance and differentiation of human ES/iPS cells].
Shiraki N; Kume S
Nihon Rinsho; 2015 May; 73(5):765-72. PubMed ID: 25985628
[TBL] [Abstract][Full Text] [Related]
19. Extrinsic factors derived from mouse embryonal carcinoma cell lines maintain pluripotency of mouse embryonic stem cells through a novel signal pathway.
Kawazoe S; Ikeda N; Miki K; Shibuya M; Morikawa K; Nakano S; Oshimura M; Hisatome I; Shirayoshi Y
Dev Growth Differ; 2009 Feb; 51(2):81-93. PubMed ID: 19207180
[TBL] [Abstract][Full Text] [Related]
20. Anti-aging activity of the Ink4/Arf locus.
Matheu A; Maraver A; Collado M; Garcia-Cao I; Cañamero M; Borras C; Flores JM; Klatt P; Viña J; Serrano M
Aging Cell; 2009 Apr; 8(2):152-61. PubMed ID: 19239418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
